STSS
Sharps Technology, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$1.27
−2.31%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.5M | 204.1K | — | — | — |
| Cost of Revenue | (150.5K) | 617.4K | 773.9K | 891.2K | 654.6K |
| Gross Profit | 324.7K | (413.3K) | (773.9K) | (891.2K) | (654.6K) |
| Operating Expenses | |||||
| R&D Expense | 541.1K | 198.8K | (58.0K) | 729.5K | 1.6M |
| SG&A Expense | 28.3M | 19.5M | 7.1M | 8.5M | 6.5M |
| General & Admin Expense | 23.2M | 19.5M | — | 8.5M | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 9.7M | (6.8M) | — | (15.2K) | — |
| Total Operating Expenses | 38.6M | 12.9M | 7.1M | 9.2M | 8.1M |
| Cost and Expenses | 38.4M | 13.5M | 7.9M | 10.1M | 8.7M |
| Operating Income (EBIT) | (36.2M) | (13.3M) | (7.9M) | (10.1M) | (8.7M) |
| Non-Operating | |||||
| Interest Income | 244.0K | — | 40.3K | 138.1K | 1.3K |
| Interest Expense | 197.3K | 416.7K | 1.7M | — | 1.3M |
| Net Interest Income | 123.4K | (416.7K) | (1.7M) | 138.1K | (1.3M) |
| Other Non-Op Income/Expense | (349.1M) | (257.0M) | (1.5M) | 255.0K | 4.1M |
| Non-Operating Income (excl Interest) | 333.0M | 256.6M | (235.5K) | (255.0K) | (5.4M) |
| EBT (Pre-Tax Income) | (385.3M) | (270.3M) | (9.3M) | (9.9M) | (4.6M) |
| Income Tax Expense | — | — | (30.0K) | (30.0K) | — |
| Bottom Line | |||||
| Net Income | (397.5M) | (282.5M) | (9.3M) | (9.8M) | (4.6M) |
| Earnings from Cont. Ops | (385.3M) | (270.3M) | (9.3M) | (9.8M) | (4.6M) |
| Earnings from Discont. Ops | — | (12.2M) | — | — | — |
| Bottom Line Net Income | (397.5M) | (282.5M) | (9.3M) | (9.8M) | (4.6M) |
| Per Share | |||||
| Basic EPS | ($12.10) | ($11.16) | ($2,220.05) | ($4,983.99) | ($3,780.28) |
| Diluted EPS | ($12.10) | ($11.16) | ($2,220.05) | ($4,983.99) | ($3,780.28) |
| Revenue Per Share | $0.03 | $0.01 | $0.00 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 72.1M | 25.3M | 4187 | 1974 | 1227 |
| Diluted Shares Outstanding | 72.1M | 25.3M | 4187 | 1974 | 1227 |
| Profitability Metrics | |||||
| EBITDA | (369.0M) | (269.7M) | (6.8M) | (9.0M) | (2.7M) |
| D&A | (116.5K) | 132.5K | 773.9K | 891.2K | 654.6K |
| EBIT | (345.8M) | (269.9M) | (7.6M) | (9.9M) | (3.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026